BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839
37 results:

  • 1. chd4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
    Geyer F; Geyer M; Reuning U; Klapproth S; Wolff KD; Nieberler M
    Sci Rep; 2024 Apr; 14(1):8286. PubMed ID: 38594331
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular subtyping of head and neck cancer - Clinical applicability and correlations with morphological characteristics.
    Stögbauer F; Otto R; Jöhrens K; Tinhofer I; Keilholz U; Poremba C; Keller U; Leser U; Weichert W; Boxberg M; Klinghammer K
    Oral Oncol; 2024 Feb; 149():106678. PubMed ID: 38219707
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Performance of the Winning Algorithms of the RSNA 2022 Cervical Spine Fracture Detection Challenge.
    Lee GR; Flanders AE; Richards T; Kitamura F; Colak E; Lin HM; Ball RL; Talbott J; Prevedello LM
    Radiol Artif Intell; 2024 Jan; 6(1):e230256. PubMed ID: 38169426
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
    Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in head and neck Squamous Cell Carcinoma.
    Bredel M; Kim H; Bonner JA
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362284
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Unclassified Neuroendocrine Tumor with a Novel chd4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged head and neck Malignancies.
    Miller DL; Palsgrove DN; Rijal A; Hathuc V; Chernock R; Gagan J; Bishop JA
    Head Neck Pathol; 2022 Sep; 16(3):928-933. PubMed ID: 35218513
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of Prognostic Biomarkers in Papillary Thyroid cancer and Developing Non-Invasive Diagnostic Models Through Integrated Bioinformatics Analysis.
    Oskouie AA; Ahmadi MS; Taherkhani A
    Microrna; 2022; 11(1):73-87. PubMed ID: 35068400
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible.
    Oblak T; Perhavec A; Hocevar M; Peric B
    Langenbecks Arch Surg; 2021 Sep; 406(6):2011-2017. PubMed ID: 34097134
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. chd4 Predicts Aggressiveness in PTC Patients and Promotes cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Postoperative radiotherapy is associated with improved survival in pT1-2N1 oral and oropharyngeal cancer without adequate neck dissection.
    Yang CC; Kang BH; Liu WS; Yin CH; Lee CC
    Radiat Oncol; 2021 Jan; 16(1):6. PubMed ID: 33407647
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The underlying molecular mechanism and identification of transcription factor markers for laryngeal squamous cell carcinoma.
    Mo BY; Li GS; Huang SN; He WY; Xie LY; Wei ZX; Su YS; Liang Y; Yang L; Ye C; Dai WB; Ruan L
    Bioengineered; 2021 Dec; 12(1):208-224. PubMed ID: 33315534
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Access to preventive care services and stage at diagnosis in head and neck cancer.
    Farquhar DR; Lenze NR; Masood MM; Divaris K; Tasoulas J; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough W; Zanation AM; Olshan AF
    Head Neck; 2020 Oct; 42(10):2841-2851. PubMed ID: 32618052
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: A population-based study.
    Wu J; Zhou Q; Pan Z; Wang Y; Hu L; Chen G; Wang S; Lyu J
    Medicine (Baltimore); 2020 Jan; 99(4):e18974. PubMed ID: 31977914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Correlation Between Electrophysiological Changes and Outcomes of Vocal Cord Function in 1764 Recurrent Laryngeal Nerves with Visual Integrity During Thyroidectomy.
    Yuan Q; Wu G; Hou J; Liao X; Liao Y; Chiang FY
    Thyroid; 2020 May; 30(5):739-745. PubMed ID: 31880997
    [No Abstract]    [Full Text] [Related]  

  • 15. Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid cancer.
    Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Albalawy WN; Parvathareddy SK; Al-Sobhi SS; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
    Thyroid; 2020 Jan; 30(1):42-56. PubMed ID: 31668133
    [No Abstract]    [Full Text] [Related]  

  • 16. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.
    Yuce Sari S; Cengiz M; Dauletkazin A; Yazici G; Gultekin M; Hurmuz P; Yildiz F; Zorlu F; Gurkaynak M; Akyol F; Ozyigit G
    Cancer Radiother; 2019 Dec; 23(8):853-859. PubMed ID: 31640927
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).
    Klinghammer K; Gauler T; Dietz A; Grünwald V; Stöhlmacher J; Knipping S; Schroeder M; Guntinas-Lichius O; Frickhofen N; Lindeman HW; Fietkau R; Haxel B; Große-Thie C; Maschmeyer G; Zipfel M; Martus P; Knoedler M; Keilholz U
    Eur J Cancer; 2019 Nov; 122():53-60. PubMed ID: 31618704
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
    Segal NH; Ou SI; Balmanoukian A; Fury MG; Massarelli E; Brahmer JR; Weiss J; Schöffski P; Antonia SJ; Massard C; Zandberg DP; Khleif SN; Xiao F; Rebelatto MC; Steele KE; Robbins PB; Angra N; Song X; Abdullah S; Butler M
    Eur J Cancer; 2019 Mar; 109():154-161. PubMed ID: 30731276
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
    Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
    J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.